特殊情况内膜癌放疗.ppt

特殊情况内膜癌的放疗 ;因内科疾病无法手术的内膜癌;;Medically inoperable stage I adenocarcinoma of the endometrium treated with radiotherapy lone;Systemic review: Radiation therapy alone in medical non-operable endometrial carcinoma;治疗效果;Image-based three-dimensional conformal brachytherapy for medically inoperable endometrial carcinoma;Image-based three-dimensional conformal brachytherapy for medically inoperable endometrial carcinoma;;Consensus statement for brachytherapy for the treatment of medically inoperable endometrial cancer;Consensus statement for brachytherapy for the treatment of medically inoperable endometrial cancer;Consensus statement for brachytherapy for the treatment of medically inoperable endometrial cancer;Consensus statement for brachytherapy for the treatment of medically inoperable endometrial cancer;推荐的EBRT+BT剂量;;复发性子宫内膜癌的放疗;;NCCN指南对复发肿瘤放疗的建议;Definitive salvage for vaginal recurrence of endometrial cancer: The impact of modern intensity-modulated-radiotherapy with image-based HDR brachytherapy and the interplay of the PORTEC 1 risk stratification;Definitive salvage for vaginal recurrence of endometrial cancer: The impact of modern intensity-modulated-radiotherapy with image-based HDR brachytherapy and the interplay of the PORTEC 1risk stratification;Definitive salvage for vaginal recurrence of endometrial cancer: The impact of modern intensity-modulated-radiotherapy with image-based HDR brachytherapy and the interplay of the PORTEC 1risk stratification;GOG0238 (NC II期研究：阴道/盆腔复发，未接受过放疗，45Gy/25f EBRT+近距离放疗/体外加量+同步顺铂化疗 对于阴道/盆腔淋巴结复发患者，存在高危复发风险的患者可考虑放疗联合化疗;放疗后复发;肿瘤性质对放疗选择的影响;ESMO-ESGO-ESTRO Consensus Conference on Endometrial Cancer;Substantial LVSI is a significant risk factor for recurrence in endometrial cancer; EBRT降低盆腔局部复发率 (HR 0.3 CI 0.1–0.8);Substantial LVSI is a significant risk factor for recurrence in endometrial cancer;A prospective phase II study of chemoradiation followed by adjuvant chemotherapy for FIGO stage I-IIIa (1988) uterine papillary s